ImmrrioN of nitric oxide synthase increases microvascular permeability in rat small intestinal villi. To determine the mechanism(s) whereby this occurs we have perfused the vasculature of rat isolated small intestines with a gelatin-containing physiological salt solution. Inclusion of NnitrO-L-argintne methyl ester (L-NAME, 100 IM) or indomethacin (1 M) in the perfusate increased leakage of injected colloidal carbon into microvessel walls. Pre-treatment with sodium nitroprusside (10 M) significantly reduced the effects of both L-NAME and indomethacin, whereas carbacycltn (1 gM) only reduced the effects of indomethacin. PD151242 (1 M) showed some antagonism towards the effects of L-NAME, but nordihydroguaiaretic acid (3ttM) was inactive. Pre-tment with cyproheptadine (10 reduced the effects of both L-NAME and indomethacin, and also significantly reduced background (control) colloidal carbon leakage. Small intestines from polymixin B-treated rats showed significantly reduced colloidal carbon leakage in response to L-NAME. This suggests that the leakage-enhancing effects of both L-NAME and indomethacin in this preparation may be mediated by mast cell-derived amines.
Introduction
Injured tissues release a complex mixture of pro-and anti-inflammatory compounds. Several authors have shown recently, for example, that endogenous nitric oxide (NO) can protect rat small intestine/mesentery preparations that are injured, resulting in less increase in microvascular permeability to either albumin a-5 or colloidal carbon, 6 or net fluid secretion into the intestinal lumen. 7 Microvascular leakage is generally thought to occur because of a loss of endothelial integrity, resulting from endothelial cell contraction. 8 Thus, endothelial cell relaxation in response to NO would be expected to bring about a recovery of this integri W. Therefore, just as vascular smooth muscles are known to relax in response to NO, 9 as a result of activation of guanylyl cyclase, 1 so too might endothelial cells. 6 Prostacyclin and certain other prostanoids can also bring about vascular relaxation, 9 and their release from endothelial cells concomitantly with NO has been demonstrated to occur in response to inflammatory stimuli in vivo, -13 in isolated vessels 14'5 and in cultured cells. [6] [7] [8] Endothelin may also be released concomitantly with NO under these circumstances. 17 '19 In addition, it has been suggested that normality in the intestinal vasculature is maintained by a balance between the opposing effects of secreted NO In the present work we have attempted to correlate these various findings and suggestions using a rat isolated perfused small intestine/ mesentery preparation, with injected colloidal carbon acting as a marker of increased microvascular permeability.
Materials and Methods
Preparation of small intestine: The basic method has been described in detail previously. 23 Briefly, rats weighing 350-500 g were killed by inhalation '4 Chemicals: N-nitro-L-arginine methyl ester (L-NAME, 100/.tM) and indomethacin ( 27 has been shown earlier to significantly reduce the t-NAME-induced leakage of colloidal carbon in this preparation. 6 In the present work it also reduced the indomethacin-induced colloidal carbon leakage (Table 1 ). In contrast, pre-treatment with carbacyclin (1 gM), a less rapidly metabolized, synthetic analogue of prostacyclin, 8 significantly reduced the indomethacin-induced colloidal carbon leakage but had no effect on the leakageresponse to t-NAME (Table 1) . PD151242 (1 gM), an endothelinA-receptor antagonist, 9 showed a trend towards reducing the t-NAMEinduced colloidal carbon leakage, but nordihydroguaiaretic acid (3 gM), a 5-1ipoxygenase inhibitor, 3 had no discernible effect ( 34 Mediators of Inflammation Vol 5 1996 ( Table 2 ). Cyproheptadine also completely prevented both the L-NAME-and the indomethacininduced leakage of colloidal carbon, reducing them to the same low value that was seen with cyproheptadine alone (Table 2) .
Effects of pre-treatment with polymixin B: There was a significant reduction in colloidal carbon leakage in the L-NAME-treated group of preparations from rats pre-treated with polymixin B when compared with rats not so pre-treated ( 34 Reasons for these tissue differences remain to be explored.
5-Lipoxygenase is another enzyme that is involved in arachidonic acid metabolism, but it did not appear to be involved in the present experimental situation, since nordihydroguaiaretic acid failed to reduce the leakage-producing effects of t-NAME (Table 1 ). This contrasts with the report that BW A137C, another 5-1ipoxy-genase inhibitor, 3 can protect rat colonic microvessels against the permeability-enhancing effects of L-NAME. 2 However, the latter experiments were carried out in vivo, and with lipopolysaccharide co-administered to enhance the effects of L-NAME. In contrast, the present experiments were performed in vitro, and without augmentation of the actions of t-NAME. Which of these several experimental differences is responsible for the differing results obtained is not known, but it cautions against any simplistic extrapolation of the present findings to in vivo situations.
Rats injected i.v. with t-NAME have been reported to show modest increases in the plasma levels of endothelin-1. 5 Similarly, in the present experiments there was no significant reduction (Bonferroni's test) in the t-NAME-induced colloidal carbon leakage in vitro after pre-treatment with PD151242 (Table 1) , although the reduction showed some significance after applying a Student t-test (p < 0.05). We have reported previously that exogenously applied endothelin-1 increases collodial carbon leakage in this preparation to some extent, but it is much more potent as a vasoconstrictor. 36 Mast cell degranulation is known to be involved in ischaemia-reperfusion injury in the rat small intestine. 2'21 Moreover, Table 1 shows a reduction in background colloidal carbon leakage as a result of pre-treatment with cyproheptadine. Furthermore, Table 2 shows that colloidal carbon leakage is reduced to the same very low level by treatment with cyproheptadine both in the absence and presence of either L-NAME or indomethacin. This suggests that mast cellderived histamine and/or 5-hydroxytryptamine mediate part of the colloidal carbon leakage seen in the controls, as well as the increased leakage shown by tissues exposed to t-NAME or indomethacin. It is particularly significant, therefore, that the small intestine/mesentery preparations derived from rats pre-treated with polymixin B, in order to deplete the mast cell stores of amines, 24'3 also showed very little colloidal carbon leakage in response to L-NAME. All these results point to mast cell-derived amines controlling microvascular permeability in this preparation, and it may be that these amines perform the same function as lipopolysaccharide in vivo. '4 Mast cell-derived mediators have been shown previously to be involved in the t-NAMEinduced epithelial permeability enhancement seen in rat small intestine in vivo. 37 Since mast cells are also thought to secrete NO, and since this NO may actually stabilize those same cells which manufacture it, 22 experiments were performed in which sodium nitroprusside was added to the perfusate from the outset in order to mimic and augment the actions of endogenous NO. Background colloidal carbon leakage 
